Food inhibits the oral bioavailability of the major green tea antioxidant epigallocatechin gallate in humans

Antioxidants

Volumn 4, Issue 2, 2015, Pages 373-393

  Naumovski, Nenad ^a,b   Blades, Barbara L ^b   Roach, Paul D ^b  

^a UNIVERSITY OF CANBERRA   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

EGCG; Functional foods; Green tea catechins; Systemic absorption

Indexed keywords

EID: 84984780964     PISSN: None     EISSN: 20763921     Source Type: Journal    
DOI: 10.3390/antiox4020373     Document Type: Article

References (58)

1. Gundimeda, U.; McNeill, T.H.; Barseghian, B.A.; Tzeng, W.; Rayudu, D.; Cadenas, E.; Gopalakrishna, R. Polyphenols from green tea prevent antineuritogenic action of Nogo-A via 67-kDa laminin receptor and hydrogen peroxide. J. Neurochem. 2015, 132, 70-84.
2. Narotzki, B.; Reznick, A.Z.; Mitki, T.; Aizenbud, D.; Levy, Y. Green tea drinking improves erythrocytes and saliva oxidative status in the elderly. Adv. Exp. Med. Biol. 2015, 832, 25-33.
3. Zhao, C.; Li, C.; Liu, S.; Yang, L. The galloyl catechins contributing to main antioxidant capacity of tea made from Camellia sinensis in China. Sci. World J. 2014, 2014, 1-11.
4. Erba, D.; Riso, P.; Bordoni, A.; Foti, P.; Biagi, P.L.; Testolin, G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J. Nutr. Biochem. 2005, 16, 144-149.
5. Kuriyama, S.; Shimazu, T.; Ohmori, K.; Kikuchi, N.; Nakaya, N.; Nishino, Y.; Tsubono, Y.; Tsuji, I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study. JAMA 2006, 296, 1255-1265.
6. Bhatti, S.K.; O’Keefe, J.H.; Lavie, C.J. Coffee and tea: Perks for health and longevity? Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 688-697.
7. Mineharu, Y.; Koizumi, A.; Wada, Y.; Iso, H.; Watanabe, Y.; Date, C.; Yamamoto, A.; Kikuchi, S.; Inaba, Y.; Toyoshima, H., et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J. Epidemiol. Community Health 2011, 65, 230-240.
8. Nabavi, S.M.; Daglia, M.; Moghaddam, A.H.; Nabavi, S.F.; Curti, V. Tea consumption and risk of ischemic stroke: A brief review of the literature. Curr. Pharm. Biotechnol. 2014, 15, 298-303.
9. Suzuki, E.; Yorifuji, T.; Takao, S.; Komatsu, H.; Sugiyama, M.; Ohta, T.; Ishikawa-Takata, K.; Doi, H. Green tea consumption and mortality among Japanese elderly people: The prospective Shizuoka elderly cohort. Ann. Epidemiol. 2009, 19, 732-739.
10. Sano, J.; Inami, S.; Seimiya, K.; Ohba, T.; Sakai, S.; Takano, T.; Mizuno, K. Effects of green tea intake on the development of coronary artery disease. Circ. J. 2004, 68, 665-670.
11. Tokunaga, S.; White, I.R.; Frost, C.; Tanaka, K.; Kono, S.; Tokudome, S.; Akamatsu, T.; Moriyama, T.; Zakouji, H. Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann. Epidemiol. 2002, 12, 157-165.
12. Mielgo-Ayuso, J.; Barrenechea, L.; Alcorta, P.; Larrarte, E.; Margareto, J.; Labayen, I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: Randomised, double-blind, placebo-controlled clinical trial. Br. J. Nutr. 2014, 111, 1263-1271.
13. Uchiyama, Y.; Suzuki, T.; Mochizuki, K.; Goda, T. Dietary supplementation with (−)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (Gk) rats. J. Agric. Food Chem. 2013, 61, 11410-11417.
14. Nagle, D.G.; Ferreira, D.; Zhou, Y.D. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 2006, 67, 1849-1855.
15. Ahmad, R.S.; Butt, M.S.; Huma, N.; Sultan, M.T. Green tea catechins based functional drink (Green cool) improves the antioxidant status of SD rats fed on high cholesterol and sucrose diets. Pak. J. Pharm. Sci. 2013, 26, 721-726.
16. Munir, K.M.; Chandrasekaran, S.; Gao, F.; Quon, M.J. Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: Therapeutic implications for diabetes and its cardiovascular complications. Am. J. Physiol. Endocrinol. Metab. 2013, 305, E679-E686.
17. Raederstorff, D.G.; Schlachter, M.F.; Elste, V.; Weber, P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem. 2003, 14, 326-332.
18. Koo, S.I.; Noh, S.K. Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. J. Nutr. Biochem. 2007, 18, 179-183.
19. Bursill, C.A.; Roach, P.D. A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids 2007, 42, 621-627.
20. Bursill, C.A.; Roach, P.D. Modulation of cholesterol metabolism by the green tea polyphenol (−)-epigallocatechin gallate in cultured human liver (HepG2) cells. J. Agric. Food. Chem. 2006, 54, 1621-1626.
21. Bursill, C.A.; Abbey, M.; Roach, P.D. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 2007, 193, 86-93.
22. Bursill, C.; Roach, P.D.; Bottema, C.D.; Pal, S. Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding Protein in HepG2 liver cells. J. Agric. Food Chem. 2001, 49, 5639-5645.
23. Nantz, M.P.; Rowe, C.A.; Bukowski, J.F.; Percival, S.S. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 2009, 25, 147-154.
24. Stalmach, A.; Troufflard, S.; Serafini, M.; Crozier, A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res. 2009, 53 (Suppl. S1), S44-S53.
25. Fu, T.; Liang, J.; Han, G.; Lv, L.; Li, N. Simultaneous determination o fthe major active components of tea polyphenols in rat plasma by a simple and specific HPLC assay. J. Chromatogr. B 2008, 875, 363-367.
26. Ullmann, U.; Haller, J.; Bakker, G.C.; Brink, E.J.; Weber, P. Epigallocatechin gallate (EGCG) (TEAVIGO) does not impair nonhaem-iron absorption in man. Phytomedicine 2005, 12, 410-415.
27. Ullmann, U.; Haller, J.; Decourt, J.P.; Girault, N.; Girault, J.; Richard-Caudron, A.S.; Pineau, B.; Weber, P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 2003, 31, 88-101.
28. Wolfram, S.; Raederstorff, D.; Wang, Y.; Teixeira, S.R.; Elste, V.; Weber, P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann. Nutr. Metab. 2005, 49, 54-63.
29. Roach, P.D.; Le, V.H.; Naumovski, N.; Blades, B. Despite its instability, epigallocatechin gallate lowers serum cholesterol in the hypercholesterolaemic rabbit. Atheroscler. Suppl. 2006, 7, 441.
30. Wang, R.; Zhou, W. Stability of tea catechins in the breadmaking process. J. Agric. Food Chem. 2004, 52, 8224-8229.
31. Wang, R.; Zhou, W.; Jiang, X. Reaction kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range. J. Agric. Food Chem. 2008, 56, 2694-2701.
32. Wang, R.; Zhou, W.; Wen, R.A. Kinetic study of the thermal stability of tea catechins in aqueous systems using a microwave reactor. J. Agric. Food Chem. 2006, 54, 5924-5932.
33. Chen, Z.; Zhu, Q.Y.; Tsang, D.; Huang, Y. Degradation of green tea catechins in tea drinks. J. Agric. Food Chem. 2001, 49, 477-482.
34. Proniuk, S.; Liederer, B.M.; Blanchard, J. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J. Pharm. Sci. 2002, 91, 111-116.
35. Dube, A.; Ng, K.; Nicolazzo, J.A.; Larson, I. Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution. Food Chem. 2010, 122, 662-667.
36. Laparra, J.M.; Sanz, Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol. Res. 2010, 61, 219-225.
37. Hirun, S.; Roach, P. A study of stability of (−)-epigallocatechin gallate (EGCG) from green tea in a frozen product. Int. Food Res. J. 2011, 18, 1261-1264.
38. Green, R.J.; Murphy, A.S.; Schulz, B.; Watkins, B.A.; Ferruzzi, M.G. Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol. Nutr. Food Res. 2007, 51, 1152-1162.
39. Mereles, D.; Hunstein, W. Epigallocatechin-3-gallate (EGCG) for clinical trials: More pitfalls than promises? Int. J.Mol. Sci. 2011, 12, 5592-5603.
40. Lee, M.J.; Maliakal, P.; Chen, L.; Meng, X.; Bondoc, F.Y.; Prabhu, S.; Lambert, G.; Mohr, S.; Yang, C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol. Biomark. Prev. 2002, 11, 1025-1032.
41. Chow, H.H.; Cai, Y.; Hakim, I.A.; Crowell, J.A.; Shahi, F.; Brooks, C.A.; Dorr, R.T.; Hara, Y.; Alberts, D.S. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 2003, 9, 3312-3319.
42. Chow, H.H.; Hakim, I.A.; Vining, D.R.; Crowell, J.A.; Ranger-Moore, J.; Chew, W.M.; Celaya, C.A.; Rodney, S.R.; Hara, Y.; Alberts, D.S. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin. Cancer Res. 2005, 11, 4627-4633.
43. Vuong, Q.V.; Golding, J.B.; Nguyen, M.; Roach, P.D. Extraction and isolation of catechins from tea. J. Sep. Sci. 2010, 33, 3415-3428.
44. Vuong, Q.V.; Golding, J.B.; Stathopoulos, C.E.; Nguyen, M.H.; Roach, P.D. Optimizing conditions for the extraction of catechins from green tea using hot water. J. Sep. Sci. 2011, 34, 3099-3106.
45. FDA. Bioavailability and bioequivalence studies for orally administered drug products-General considerations. In Guidance for Industry, 1st ed.; Food and Drug Administration, Ed.; U.S. Department of Health and Human Services: Rockville, MD, USA, 2003; p. 23.
46. Maron, D.J.; Lu, G.P.; Cai, N.S.; Wu, Z.G.; Li, Y.H.; Chen, H.; Zhu, J.Q.; Jin, X.J.; Woulters, B.C.; Zhao, J. Cholesterol-lowering effect of a theaflin-enriched green tea extract. Arch. Intern. Med. 2003, 163, 1448-1453.
47. Adiyaman, A.; Verhoeff, R.; Lenders, J.W.; Deinum, J.; Thien, T. The position of the arm during blood pressure measurement in sitting position. Blood Pressure Monit. 2006, 11, 309-313.
48. Sauter, R.; Steinijans, V.W.; Diletti, E.; Bohm, A.; Schulz, H.U. Presentation of results from bioequivalence studies. Int. J. Clin. Pharm. 1992, 30, 233-256.
49. Welling, P.G. Effects of food on drug absorption. Pharmacol. Ther. 1989, 43, 425-441.
50. Spencer, J.P.; Schroeter, H.; Rechner, A.R.; Rice-Evans, C. Bioavailability of flavan-3-ols and procyanidins: Gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid. Redox Signal. 2001, 3, 1023-1039.
51. Holladay, J.W. Biofarmaceutics of orally ingested products. In Handbook of Food-Drug Interactions, McCabe, B.J., Wolfe, J.J., Frankel, E.H., Eds.; CRC Press LLC: Boca Raton, FL, USA, 2003.
52. Record, I.R.; Lane, J.M. Simulated intestinal digestion of green and black teas. Food Chem. 2001, 73, 481-486.
53. Fleisher, D.; Li, C.; Zhou, Y.; Pao, L.H.; Karim, A. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin. Pharmacokinet. 1999, 36, 233-254.
54. Chen, L.; Lee, M.J.; Li, H.; Yang, C.S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos. 1997, 25, 1045-1050.
55. Spencer, J.P. Metabolism of tea flavonoids in the gastrointestinal tract. J. Nutr. 2003, 133, 3255S-3261S.
56. Ru, Q.; Yu, H.; Huang, Q. Encapsulation of epigallocatechin-3-gallate (EGCG) using oil-in-water (O/W) submicrometer emulsions stabilized by ι-carrageenan and β-lactoglobulin. J. Agric. Food Chem. 2010, 58, 10373-10381.
57. Fang, J.Y.; Hwang, T.L.; Huang, Y.L.; Fang, C.L. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int. J. Pharm. 2006, 310, 131-138.
58. Shutava, T.G.; Balkundi, S.S.; Lvov, Y.M. (−)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsules. J. Colloid Interface Sci. 2009, 330, 276-283.